BARCLAYS PLC

Position in ACIU — AC Immune SA

CIK 312069 LONDON, X0

Position in ACIU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$17,321

+$1,397 QoQ

Shares Held

7,278

+25.7% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 43 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. ACIU ranks #314 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,321	7,278	+25.7%	Shares	Defined	2026-08-14
2026-03-31	$15,924	5,791	+114.4%	Shares	Defined	2026-05-15
2025-12-31	$8,481	2,701	-48.9%	Shares	Sole	2026-02-13
2025-09-30	$15,287	5,290	-33.1%	Shares	Sole	2026-03-31
2025-06-30	$16,051	7,907	+6.7%	Shares	Sole	2026-02-27
2025-03-31	$13,854	7,409	+26.2%	Shares	Sole	2026-03-17
2024-12-31	$15,854	5,872	+1098.4%	Shares	Sole	2026-03-19
2024-09-30	$1,852	490	-93.1%	Shares	Sole	2026-03-31
2021-09-30	$47,424	7,068	+5889.8%	Shares	Sole	2021-11-09
2021-06-30	$935	118	-69.9%	Shares	Sole	2021-08-13
2021-03-31	$2,983	392	+269.8%	Shares	Sole	2021-05-13
2020-12-31	$548	106	0.0%	Shares	Sole	2021-02-11
2020-09-30	$517	106	0.0%	Shares	Sole	2020-11-12
2020-06-30	$713	106	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.